Fairbanks Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.65M Sell
24,929
-2
-0% -$212 1.51% 23
2025
Q1
$3.1M Sell
24,931
-4,195
-14% -$521K 1.99% 18
2024
Q4
$3.59M Buy
29,126
+1,592
+6% +$196K 2.23% 16
2024
Q3
$3.07M Buy
27,534
+422
+2% +$47K 1.93% 18
2024
Q2
$2.89M Buy
27,112
+1,178
+5% +$126K 1.9% 18
2024
Q1
$3.12M Sell
25,934
-567
-2% -$68.3K 2.15% 17
2023
Q4
$3.26M Buy
26,501
+2,890
+12% +$355K 2.33% 17
2023
Q3
$3.06M Buy
23,611
+1,543
+7% +$200K 2.57% 13
2023
Q2
$2.74M Sell
22,068
-979
-4% -$121K 2.13% 17
2023
Q1
$3.37M Buy
23,047
+688
+3% +$101K 2.68% 11
2022
Q4
$3.56M Sell
22,359
-5,516
-20% -$879K 3.17% 11
2022
Q3
$3.72M Sell
27,875
-325
-1% -$43.3K 3.46% 8
2022
Q2
$4.4M Sell
28,200
-240
-0.8% -$37.4K 3.83% 8
2022
Q1
$4.43M Buy
28,440
+1,021
+4% +$159K 3.29% 9
2021
Q4
$3.49M Buy
27,419
+69
+0.3% +$8.79K 2.54% 14
2021
Q3
$3.56M Sell
27,350
-113
-0.4% -$14.7K 2.91% 11
2021
Q2
$4.88M Buy
27,463
+115
+0.4% +$20.4K 3.85% 7
2021
Q1
$4.5M Sell
27,348
-580
-2% -$95.3K 3.67% 6
2020
Q4
$4.61M Sell
27,928
-392
-1% -$64.7K 4.13% 6
2020
Q3
$4.04M Sell
28,320
-995
-3% -$142K 4.04% 6
2020
Q2
$3.61M Buy
29,315
+660
+2% +$81.3K 3.53% 8
2020
Q1
$2.86M Sell
28,655
-5,305
-16% -$529K 3.74% 6
2019
Q4
$5.07M Sell
33,960
-1,497
-4% -$223K 5.24% 3
2019
Q3
$4.54M Buy
35,457
+448
+1% +$57.4K 4.68% 6
2019
Q2
$4.99M Buy
35,009
+140
+0.4% +$20K 5.32% 5
2019
Q1
$4.99M Buy
34,869
+452
+1% +$64.6K 5.09% 5
2018
Q4
$4.27M Buy
34,417
+3,814
+12% +$473K 4.72% 4
2018
Q3
$5.15M Sell
30,603
-19
-0.1% -$3.19K 5.14% 5
2018
Q2
$5.28M Buy
30,622
+60
+0.2% +$10.3K 6.18% 4
2018
Q1
$4.62M Sell
30,562
-583
-2% -$88K 4.66% 6
2017
Q4
$4.19M Sell
31,145
-185
-0.6% -$24.9K 3.85% 6
2017
Q3
$4.58M Sell
31,330
-10
-0% -$1.46K 4.44% 6
2017
Q2
$4.87M Sell
31,340
-3,190
-9% -$496K 4.57% 6
2017
Q1
$5.01M Buy
34,530
+1,035
+3% +$150K 4.93% 6
2016
Q4
$3.65M Buy
33,495
+1,896
+6% +$207K 3.77% 6
2016
Q3
$3.84M Sell
31,599
-976
-3% -$119K 4.14% 6
2016
Q2
$4.6M Buy
+32,575
New +$4.6M 5.52% 6